DekaBank Deutsche Girozentrale’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-37,080	Closed	-$6.41M	–	1218
2015 Q1	$6.41M	Sell	37,080 -4,770	-11%	-$700K	0.08%	259
2014 Q4	$4.86M	Buy	41,850 +1,113	+3%	+$135K	0.06%	310
2014 Q3	$6.37M	Sell	40,737 -1,256	-3%	-$182K	0.09%	232
2014 Q2	$5.18M	Sell	41,993 -1,200	-3%	-$133K	0.08%	264
2014 Q1	$4.47M	Buy	43,193 +572	+1%	+$58.6K	0.07%	267
2013 Q4	$3.79M	Buy	42,621 +900	+2%	+$71.8K	0.06%	237
2013 Q3	$2.79M	Buy	+41,721	New	+$2.87M	0.05%	275

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

DekaBank Deutsche Girozentrale's SLXP Position: Q2 2015 in Review

DekaBank Deutsche Girozentrale sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 37,080 shares — an estimated $6.41M sold.

DekaBank Deutsche Girozentrale first reported a position in SLXP in Q3 2013 and held it in 7 quarters. The position peaked at $6.41M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

DekaBank Deutsche Girozentrale reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 37,080 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $6.41M.
DekaBank Deutsche Girozentrale first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 7 quarters.
DekaBank Deutsche Girozentrale's SALIX PHARMACEUTICALS LTD DEL position peaked at $6.41M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2015, filed 13 Aug 2015.